At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
ZYME ZYMEWORKS INC (US)
Not Yet Opened 12-11 16:00:00 EST
24.94
-0.93
-3.59%
盘后24.95
+0.01+0.04%
17:31 EST
High26.07Low24.79Vol640.60K
Open25.91D1 Closing25.87Amplitude4.95%
Mkt Cap1.87BTradable Cap955.19MTotal Shares74.84M
T/O16.15MT/O Rate1.67%Tradable Shares38.30M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Zymeworks Initiated at Market Outperform by Citizens
Dow Jones  ·  12-04
Zymeworks Initiated at Market Outperform by Citizens
Zymeworks Showcases Pipeline Advances at ASCO GI and J.P. Morgan Healthcare Conference
Reuters  ·  12-03
Zymeworks Showcases Pipeline Advances at ASCO GI and J.P. Morgan Healthcare Conference
Zymeworks (ZYME) Is Up 13.8% After Positive Zanidatamab Trial and Share Buyback Plan - What's Changed
Simply Wall St.  ·  11-28
Zymeworks (ZYME) Is Up 13.8% After Positive Zanidatamab Trial and Share Buyback Plan - What's Changed
Zymeworks Inc. to Participate in Major Healthcare Investor Conferences
Reuters  ·  11-24
Zymeworks Inc. to Participate in Major Healthcare Investor Conferences
LifeSci Capital Reaffirms Their Buy Rating on Zymeworks (ZYME)
TIPRANKS  ·  11-22
LifeSci Capital Reaffirms Their Buy Rating on Zymeworks (ZYME)
Zymeworks price target raised to $40 from $37 at Leerink
TIPRANKS  ·  11-20
Zymeworks price target raised to $40 from $37 at Leerink
A Look at Zymeworks (ZYME) Valuation After Breakthrough Phase 3 Cancer Trial Results
Simply Wall St.  ·  11-20
A Look at Zymeworks (ZYME) Valuation After Breakthrough Phase 3 Cancer Trial Results
Evercore ISI Sticks to Its Buy Rating for Zymeworks (ZYME)
TIPRANKS  ·  11-19
Evercore ISI Sticks to Its Buy Rating for Zymeworks (ZYME)
Analysts Offer Insights on Healthcare Companies: Zymeworks (ZYME) and Medtronic (MDT)
TIPRANKS  ·  11-19
Analysts Offer Insights on Healthcare Companies: Zymeworks (ZYME) and Medtronic (MDT)
Zymeworks Inc : Stifel Raises Target Price to $40 From $30
THOMSON REUTERS  ·  11-19
Zymeworks Inc : Stifel Raises Target Price to $40 From $30
U.S. RESEARCH ROUNDUP-Amgen, Crowdstrike, Micron Technology
Reuters  ·  11-19
U.S. RESEARCH ROUNDUP-Amgen, Crowdstrike, Micron Technology
Zymeworks Shares Fall 1.7% Premarket Day After Climbing to Four-Year High
THOMSON REUTERS  ·  11-18
Zymeworks Shares Fall 1.7% Premarket Day After Climbing to Four-Year High
Zymeworks Stock (ZYME) Soars on Positive Results for Cancer Drug Ziihera, Top Analysts Boost Price Targets
TIPRANKS  ·  11-18
Zymeworks Stock (ZYME) Soars on Positive Results for Cancer Drug Ziihera, Top Analysts Boost Price Targets
BRIEF-Zymeworks Says Authorizes $125 Million Share Repurchase Plan
Reuters  ·  11-18
BRIEF-Zymeworks Says Authorizes $125 Million Share Repurchase Plan
Zymeworks Appoints Scott Platshon as Acting Chief Investment Officer
Reuters  ·  11-18
Zymeworks Appoints Scott Platshon as Acting Chief Investment Officer
Zymeworks Inc. Announces Strategic Initiative to Optimize Future Cash Flows Through Diversified Revenue-Generating Assets, Capital Allocation, and $125 Million Share Repurchase Plan
Reuters  ·  11-18
Zymeworks Inc. Announces Strategic Initiative to Optimize Future Cash Flows Through Diversified Revenue-Generating Assets, Capital Allocation, and $125 Million Share Repurchase Plan
Zymeworks Inc - Authorizes $125 Mln Share Repurchase Plan
THOMSON REUTERS  ·  11-18
Zymeworks Inc - Authorizes $125 Mln Share Repurchase Plan
Zymeworks Announces Strategic Initiative to Optimize Value of Licensed Products by Building a Diversified Portfolio of Revenue-Generating Assets
THOMSON REUTERS  ·  11-18
Zymeworks Announces Strategic Initiative to Optimize Value of Licensed Products by Building a Diversified Portfolio of Revenue-Generating Assets
Stock Track | Zymeworks Plunges 9.29% Despite Positive Cancer Drug Trial Results
Stock Track  ·  11-18
Stock Track | Zymeworks Plunges 9.29% Despite Positive Cancer Drug Trial Results
Top Midday Gainers
MT Newswires Live  ·  11-18
Top Midday Gainers

Introduction

Company Name.
ZYMEWORKS INC (US)
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Issue price:
--